Insiders who reported open-market trades in the last 12 months at the companies Alise Reicin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Marcella K. Ruddy - $363K in TECX purchases and sales in the last 12 months
Peter McNamara - $288K in TECX purchases and sales in the last 12 months
Daniel Lochner - $130K in TECX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Alise Reicin is a corporate insider, tracked as Chief Executive Officer, Director of Tectonic Therapeutic, Inc. (TECX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alise Reicin submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Alise Reicin been buying or selling stock?
Recorded transactions: 2 open-market purchases ($106K) and 0 open-market sales across all tracked filings.
Alise Reicin is Chief Executive Officer, Director of Tectonic Therapeutic, Inc. (TECX). 10 SEC Form 4 filings on record going back to 2024, most recently on 2 October 2026. Most recent open-market trade: bought $53K of TECX on 5 March 2026. Lifetime open-market purchases: $106K.
Recent transactions
7
The latest 7 SEC Form 4 transactions reported by Alise Reicin.
InsiderAlpha's records for Alise Reicin go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. The typical open-market purchase is $53K (2 buys totaling $106K). The largest single buy on record is $53K of TECX in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
